# AbCellera Biologics Inc. > Alpha governed public record. Unknown, unavailable, and unpublished values are never inferred as zero. ## Record | Field | Value | | --- | --- | | Representation | alpha-profile-markdown-v4 | | Protocol | Alpha Governance Facts Protocol 0.1 | | Schema | alpha.governance.entity.public.v1 | | Record version | public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | | Governance record representation | alpha-governance-record-v2 | | Canonical entity | alpha:company:a5618ad8-b066-40d3-91b3-3665844a45f8 | | Entity type | Company | | Canonical URL | https://registry.alpha.ac/companies/abcellera-biologics-inc | | Publication | PUBLISHED | | Verification | source_reported | | Verification schema | alpha-verification-states-v1 | | Ownership | unclaimed | | Published claims | 19 | | Claims under review | 1 | | Evidence records | 7 | | Conflicts | 0 | | Conflicts in internal review | 0 | | Observed | 2026-10-16T13:52:00.216745+00:00 | | Last reviewed | 2026-10-16T13:52:00.216745+00:00 | ## Identity - Legal name: AbCellera Biologics Inc. - Display name: AbCellera Biologics Inc. ## Alpha Governance Record | Field | Value | | --- | --- | | Governance Record schema | alpha-governance-record-v2 | | Ontology | alpha-governance-ontology-v1 | | Record version | public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | | As of | 2026-10-16T14:49:46.270666+00:00 | | Completeness | 0.409 | | Record Quality | 0.842 | | Directors | 5 | | Committees | 4 | | Governance events | 11 | | Entity class | public_company | ## Section coverage | Section | State | | --- | --- | | identity | PUBLISHED | | corporate_structure | NOT_REVIEWED | | board | PUBLISHED | | committees | PUBLISHED | | leadership | PUBLISHED | | ownership | NOT_REVIEWED | | financials | NOT_REVIEWED | | capital_structure | PUBLISHED | | compensation | NOT_REVIEWED | | governance | NOT_REVIEWED | | shareholder_governance | NOT_REVIEWED | | audit | NOT_REVIEWED | | legal | NOT_REVIEWED | | risk | NOT_REVIEWED | | cyber | NOT_REVIEWED | | ai_governance | NOT_REVIEWED | | agent_governance | RESTRICTED | | markets_external | NOT_REVIEWED | | events | PUBLISHED | | relationships | PUBLISHED | | assessments | PUBLISHED | | evidence | PUBLISHED | ## Board - Andrew Lo, Ph.D.: Director. Status: current. Independent: true. Since: 2021-01-01. claim_id=alpha:claim:company:a5618ad8-b066-40d3-91b3-3665844a45f8:leadership_role:5 - Carl L. G. Hansen, Ph.D.: Director. Status: current. Independent: false. Since: 2012-01-01. claim_id=alpha:claim:company:a5618ad8-b066-40d3-91b3-3665844a45f8:leadership_role:6 - John S. Montalbano, CFA: Director. Status: current. Independent: true. Since: 2020-01-01. Committees: Audit (chair); Audit · Chair; Compensation; Nominating and Governance (member); Compensation (member); Nominating and Governance (member). claim_id=alpha:claim:company:a5618ad8-b066-40d3-91b3-3665844a45f8:leadership_role:7 - Michael Hayden, MBCHB (M.D.), Ph.D.: Director. Status: current. Independent: true. Since: 2019-01-01. claim_id=alpha:claim:company:a5618ad8-b066-40d3-91b3-3665844a45f8:leadership_role:8 - Véronique Lecault, Ph.D.: Director. Status: current. Independent: false. Since: 2018-01-01. claim_id=alpha:claim:company:a5618ad8-b066-40d3-91b3-3665844a45f8:leadership_role:9 ## Committees - Audit (audit). Chair: John S. Montalbano, CFA. Members: John S. Montalbano, CFA (chair, current). committee_id=alpha:committee:abcellera-biologics-inc:audit - Audit · Chair; Compensation; Nominating and Governance (audit). Chair: NOT_PUBLISHED. Members: John S. Montalbano, CFA (member, current). committee_id=alpha:committee:abcellera-biologics-inc:audit-chair-compensation-nominating-and-governance - Compensation (compensation). Chair: NOT_PUBLISHED. Members: John S. Montalbano, CFA (member, current). committee_id=alpha:committee:abcellera-biologics-inc:compensation - Nominating and Governance (nominating_governance). Chair: NOT_PUBLISHED. Members: John S. Montalbano, CFA (member, current). committee_id=alpha:committee:abcellera-biologics-inc:nominating-and-governance ## Executive leadership - Andrew Booth: Chief Financial Officer [CFO]. Status: current. claim_id=alpha:claim:company:a5618ad8-b066-40d3-91b3-3665844a45f8:leadership_role:10 - Carl L.G. Hansen, Ph.D.: Chief Executive Officer and Director [CEO]. Status: current. claim_id=alpha:claim:company:a5618ad8-b066-40d3-91b3-3665844a45f8:leadership_role:11 - Tryn Stimart: Chief Legal Officer, Chief Compliance Officer, Corporate Secretary and Privacy Officer [GC]. Status: current. claim_id=alpha:claim:company:a5618ad8-b066-40d3-91b3-3665844a45f8:leadership_role:12 - Véronique Lecault, Ph.D.: Chief Technology Officer and Director [CTO]. Status: current. claim_id=alpha:claim:company:a5618ad8-b066-40d3-91b3-3665844a45f8:leadership_role:13 ## Governance events - CFO_CHANGED: Andrew Booth executive of AbCellera Biologics Inc., effective 2026-02-24. Effective: 2026-02-24. Detected: 2026-10-16T13:52:00.216745+00:00. event_id=alpha:event:transition:n0lo4q620bsk - CEO_CHANGED: Carl L.G. Hansen, Ph.D. executive of AbCellera Biologics Inc., effective 2026-02-24. Effective: 2026-02-24. Detected: 2026-10-16T13:52:00.216745+00:00. event_id=alpha:event:transition:foxnx61lpzvt8 - GC_CHANGED: Tryn Stimart executive of AbCellera Biologics Inc., effective 2026-02-24. Effective: 2026-02-24. Detected: 2026-10-16T13:52:00.216745+00:00. event_id=alpha:event:transition:ey722z9cefmz - EXECUTIVE_APPOINTED: Véronique Lecault, Ph.D. executive of AbCellera Biologics Inc., effective 2026-02-24. Effective: 2026-02-24. Detected: 2026-10-16T13:52:00.216745+00:00. event_id=alpha:event:transition:dwkl0mmxtxku - DIRECTOR_APPOINTED: Andrew Lo, Ph.D. seat on AbCellera Biologics Inc., effective 2021-01-01. Effective: 2021-01-01. Detected: 2026-10-16T13:52:00.216745+00:00. event_id=alpha:event:transition:1pucpx9a3df1x - DIRECTOR_APPOINTED: John S. Montalbano, CFA seat on AbCellera Biologics Inc., effective 2020-01-01. Effective: 2020-01-01. Detected: 2026-10-16T13:52:00.216745+00:00. event_id=alpha:event:transition:1sciffk1f16c9u - COMMITTEE_CREATED: Audit · Chair; Compensation; Nominating and Governance committee of AbCellera Biologics Inc., effective 2020-01-01. Effective: 2020-01-01. Detected: 2026-10-16T13:52:00.216745+00:00. event_id=alpha:event:transition:13fib361bngrvi - COMMITTEE_MEMBER_ADDED: John S. Montalbano, CFA member of Audit · Chair; Compensation; Nominating and Governance, effective 2020-01-01. Effective: 2020-01-01. Detected: 2026-10-16T13:52:00.216745+00:00. event_id=alpha:event:transition:16oa7to134m6cw - DIRECTOR_APPOINTED: Michael Hayden, MBCHB (M.D.), Ph.D. seat on AbCellera Biologics Inc., effective 2019-01-01. Effective: 2019-01-01. Detected: 2026-10-16T13:52:00.216745+00:00. event_id=alpha:event:transition:19cz0qz1q6pbub - DIRECTOR_APPOINTED: Véronique Lecault, Ph.D. seat on AbCellera Biologics Inc., effective 2018-01-01. Effective: 2018-01-01. Detected: 2026-10-16T13:52:00.216745+00:00. event_id=alpha:event:transition:1su9aht14px1g7 - DIRECTOR_APPOINTED: Carl L. G. Hansen, Ph.D. seat on AbCellera Biologics Inc., effective 2012-01-01. Effective: 2012-01-01. Detected: 2026-10-16T13:52:00.216745+00:00. event_id=alpha:event:transition:294xxiuoeiom ## Scoped resources - `alpha://company/abcellera-biologics-inc` (contract): https://registry.alpha.ac/api/public/companies/abcellera-biologics-inc?format=record - `alpha://company/abcellera-biologics-inc/identity` (contract): https://registry.alpha.ac/api/public/companies/abcellera-biologics-inc?format=record§ion=identity - `alpha://company/abcellera-biologics-inc/corporate-structure` (contract): https://registry.alpha.ac/api/public/companies/abcellera-biologics-inc?format=record§ion=corporate-structure - `alpha://company/abcellera-biologics-inc/board` (contract): https://registry.alpha.ac/api/public/companies/abcellera-biologics-inc?format=record§ion=board - `alpha://company/abcellera-biologics-inc/committees` (contract): https://registry.alpha.ac/api/public/companies/abcellera-biologics-inc?format=record§ion=committees - `alpha://company/abcellera-biologics-inc/leadership` (contract): https://registry.alpha.ac/api/public/companies/abcellera-biologics-inc?format=record§ion=leadership - `alpha://company/abcellera-biologics-inc/ownership` (contract): https://registry.alpha.ac/api/public/companies/abcellera-biologics-inc?format=record§ion=ownership - `alpha://company/abcellera-biologics-inc/financials` (contract): https://registry.alpha.ac/api/public/companies/abcellera-biologics-inc?format=record§ion=financials - `alpha://company/abcellera-biologics-inc/capital-structure` (contract): https://registry.alpha.ac/api/public/companies/abcellera-biologics-inc?format=record§ion=capital-structure - `alpha://company/abcellera-biologics-inc/compensation` (contract): https://registry.alpha.ac/api/public/companies/abcellera-biologics-inc?format=record§ion=compensation - `alpha://company/abcellera-biologics-inc/governance` (contract): https://registry.alpha.ac/api/public/companies/abcellera-biologics-inc?format=record§ion=governance - `alpha://company/abcellera-biologics-inc/shareholder-governance` (contract): https://registry.alpha.ac/api/public/companies/abcellera-biologics-inc?format=record§ion=shareholder-governance - `alpha://company/abcellera-biologics-inc/audit` (contract): https://registry.alpha.ac/api/public/companies/abcellera-biologics-inc?format=record§ion=audit - `alpha://company/abcellera-biologics-inc/legal` (contract): https://registry.alpha.ac/api/public/companies/abcellera-biologics-inc?format=record§ion=legal - `alpha://company/abcellera-biologics-inc/risk` (contract): https://registry.alpha.ac/api/public/companies/abcellera-biologics-inc?format=record§ion=risk - `alpha://company/abcellera-biologics-inc/cyber` (contract): https://registry.alpha.ac/api/public/companies/abcellera-biologics-inc?format=record§ion=cyber - `alpha://company/abcellera-biologics-inc/ai-governance` (contract): https://registry.alpha.ac/api/public/companies/abcellera-biologics-inc?format=record§ion=ai-governance - `alpha://company/abcellera-biologics-inc/agents` (contract): https://registry.alpha.ac/api/public/companies/abcellera-biologics-inc?format=record§ion=agents - `alpha://company/abcellera-biologics-inc/ecosystem` (contract): https://registry.alpha.ac/api/public/companies/abcellera-biologics-inc?format=record§ion=ecosystem - `alpha://company/abcellera-biologics-inc/events` (contract): https://registry.alpha.ac/api/public/companies/abcellera-biologics-inc?format=record§ion=events - `alpha://company/abcellera-biologics-inc/relationships` (contract): https://registry.alpha.ac/api/public/companies/abcellera-biologics-inc?format=record§ion=relationships - `alpha://company/abcellera-biologics-inc/assessments` (contract): https://registry.alpha.ac/api/public/companies/abcellera-biologics-inc?format=record§ion=assessments - `alpha://company/abcellera-biologics-inc/evidence` (contract): https://registry.alpha.ac/api/public/companies/abcellera-biologics-inc?format=record§ion=evidence ## Role modules - NOT_ASSERTED ## Attention - NO_RECORDS_FOUND ## Committee data - Claim alpha:claim:company:a5618ad8-b066-40d3-91b3-3665844a45f8:committee_appointment:15: `{"kind":"committee_appointment","original_name":"Audit","category":"audit","role":"chair","person":{"alpha_id":"alpha:person:john-s-montalbano-cfa","name":"John S. Montalbano, CFA"},"source_id":"board_seats"}` - Claim alpha:claim:company:a5618ad8-b066-40d3-91b3-3665844a45f8:committee_appointment:17: `{"kind":"committee_appointment","original_name":"Compensation","category":"compensation","role":"member","person":{"alpha_id":"alpha:person:john-s-montalbano-cfa","name":"John S. Montalbano, CFA"},"source_id":"board_seats"}` - Claim alpha:claim:company:a5618ad8-b066-40d3-91b3-3665844a45f8:committee_appointment:19: `{"kind":"committee_appointment","original_name":"Nominating and Governance","category":"nominating_governance","role":"member","person":{"alpha_id":"alpha:person:john-s-montalbano-cfa","name":"John S. Montalbano, CFA"},"source_id":"board_seats"}` ## Leadership - Andrew Lo, Ph.D.: Director. Claim: alpha:claim:company:a5618ad8-b066-40d3-91b3-3665844a45f8:leadership_role:5. Valid from: 2021-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:80661343e38e5b13e95b8c2913e16b510aa58a60c350b5989598ff94ffa6cc90. - Carl L. G. Hansen, Ph.D.: Director. Claim: alpha:claim:company:a5618ad8-b066-40d3-91b3-3665844a45f8:leadership_role:6. Valid from: 2012-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:80661343e38e5b13e95b8c2913e16b510aa58a60c350b5989598ff94ffa6cc90. - John S. Montalbano, CFA: Director, Audit · Chair; Compensation; Nominating and Governance. Claim: alpha:claim:company:a5618ad8-b066-40d3-91b3-3665844a45f8:leadership_role:7. Valid from: 2020-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:80661343e38e5b13e95b8c2913e16b510aa58a60c350b5989598ff94ffa6cc90. - Michael Hayden, MBCHB (M.D.), Ph.D.: Director. Claim: alpha:claim:company:a5618ad8-b066-40d3-91b3-3665844a45f8:leadership_role:8. Valid from: 2019-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:80661343e38e5b13e95b8c2913e16b510aa58a60c350b5989598ff94ffa6cc90. - Véronique Lecault, Ph.D.: Director. Claim: alpha:claim:company:a5618ad8-b066-40d3-91b3-3665844a45f8:leadership_role:9. Valid from: 2018-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:80661343e38e5b13e95b8c2913e16b510aa58a60c350b5989598ff94ffa6cc90. - Andrew Booth: Chief Financial Officer. Claim: alpha:claim:company:a5618ad8-b066-40d3-91b3-3665844a45f8:leadership_role:10. Valid from: 2026-02-24. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:76d3a773131c0efe2afe7c296102446d1b4311043f79feeb77d38a599288d09b. - Carl L.G. Hansen, Ph.D.: Chief Executive Officer and Director. Claim: alpha:claim:company:a5618ad8-b066-40d3-91b3-3665844a45f8:leadership_role:11. Valid from: 2026-02-24. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:de6b953d9d94b8e75a4e3cdc2ef56bdc05edd9b879ca97a605e824935e6a5dd9. - Tryn Stimart: Chief Legal Officer, Chief Compliance Officer, Corporate Secretary and Privacy Officer. Claim: alpha:claim:company:a5618ad8-b066-40d3-91b3-3665844a45f8:leadership_role:12. Valid from: 2026-02-24. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:5679980b0628dae465bc1a2c857976b9891b0ef5b3e80d03bf85fbabea09e799. - Véronique Lecault, Ph.D.: Chief Technology Officer and Director. Claim: alpha:claim:company:a5618ad8-b066-40d3-91b3-3665844a45f8:leadership_role:13. Valid from: 2026-02-24. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:ab5685e0ca0564938730de6b5b6a444e98b6a78e792d2e19d290931594142c88. ## Roles - PUBLISHED ## Governance - NOT_ASSERTED ## Board committees - Audit: Chair John S. Montalbano, CFA; Members John S. Montalbano, CFA (Chair). Claim: alpha:claim:company:a5618ad8-b066-40d3-91b3-3665844a45f8:committee_record:14. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:4f89987e03bcdcef009decbc33bbe0535331a8d140e3c27fd290edb66af94628. - Compensation: Chair not stated; Members John S. Montalbano, CFA. Claim: alpha:claim:company:a5618ad8-b066-40d3-91b3-3665844a45f8:committee_record:16. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:4f89987e03bcdcef009decbc33bbe0535331a8d140e3c27fd290edb66af94628. - Nominating and Governance: Chair not stated; Members John S. Montalbano, CFA. Claim: alpha:claim:company:a5618ad8-b066-40d3-91b3-3665844a45f8:committee_record:18. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:4f89987e03bcdcef009decbc33bbe0535331a8d140e3c27fd290edb66af94628. ## Financials - NOT_ASSERTED ## Workforce - NOT_ASSERTED ## Market and index context - PUBLISHED ## Legal Name - AbCellera Biologics Inc.. Claim: alpha:claim:company:a5618ad8-b066-40d3-91b3-3665844a45f8:legal_name:1. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:460cdde3c178ff27bd697f73659e8c821bf872d67590b7f735472276e19ee2ae. ## Entity Status - Public listing published. Claim: alpha:claim:company:a5618ad8-b066-40d3-91b3-3665844a45f8:entity_status:3. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:460cdde3c178ff27bd697f73659e8c821bf872d67590b7f735472276e19ee2ae. ## Published Fact - US. Claim: alpha:claim:company:a5618ad8-b066-40d3-91b3-3665844a45f8:published_fact:4. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:460cdde3c178ff27bd697f73659e8c821bf872d67590b7f735472276e19ee2ae. ## Committee Appointment - John S. Montalbano, CFA: chair, Audit. Claim: alpha:claim:company:a5618ad8-b066-40d3-91b3-3665844a45f8:committee_appointment:15. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:4f89987e03bcdcef009decbc33bbe0535331a8d140e3c27fd290edb66af94628. - John S. Montalbano, CFA: member, Compensation. Claim: alpha:claim:company:a5618ad8-b066-40d3-91b3-3665844a45f8:committee_appointment:17. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:4f89987e03bcdcef009decbc33bbe0535331a8d140e3c27fd290edb66af94628. - John S. Montalbano, CFA: member, Nominating and Governance. Claim: alpha:claim:company:a5618ad8-b066-40d3-91b3-3665844a45f8:committee_appointment:19. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:4f89987e03bcdcef009decbc33bbe0535331a8d140e3c27fd290edb66af94628. ## Security Listing - ABCL (NASDAQ). Claim: alpha:claim:company:a5618ad8-b066-40d3-91b3-3665844a45f8:security_listing:20. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:460cdde3c178ff27bd697f73659e8c821bf872d67590b7f735472276e19ee2ae. ## Coverage states | Field | Value | | --- | --- | | Identity | PUBLISHED | | Business | PUBLISHED | | Leadership | PUBLISHED | | Board and committees | PUBLISHED | | Governance | NOT_ASSERTED | | Financials | NOT_ASSERTED | | Workforce | NOT_ASSERTED | | Ownership | NOT_ASSERTED | | Ratings | NOT_PUBLISHED | | Market and index context | PUBLISHED | ## Public sources - alpha:projection-evidence:460cdde3c178ff27bd697f73659e8c821bf872d67590b7f735472276e19ee2ae: [Alpha canonical company public projection](https://www.alpha.ac/api/public/companies/abcellera-biologics-inc). - alpha:projection-evidence:document:80661343e38e5b13e95b8c2913e16b510aa58a60c350b5989598ff94ffa6cc90: [AbCellera Biologics Inc. DEF 14A 2025-04-29](https://www.sec.gov/Archives/edgar/data/1703057/000162828025020703/abcl-20250429.htm). - alpha:projection-evidence:document:76d3a773131c0efe2afe7c296102446d1b4311043f79feeb77d38a599288d09b: [ABCL 10-K executive officers](https://www.sec.gov/Archives/edgar/data/1703057/000170305726000012/abcl-20251231.htm). - alpha:projection-evidence:document:de6b953d9d94b8e75a4e3cdc2ef56bdc05edd9b879ca97a605e824935e6a5dd9: [ABCL 10-K executive officers](https://www.sec.gov/Archives/edgar/data/1703057/000170305726000012/abcl-20251231.htm). - alpha:projection-evidence:document:5679980b0628dae465bc1a2c857976b9891b0ef5b3e80d03bf85fbabea09e799: [ABCL 10-K executive officers](https://www.sec.gov/Archives/edgar/data/1703057/000170305726000012/abcl-20251231.htm). - alpha:projection-evidence:document:ab5685e0ca0564938730de6b5b6a444e98b6a78e792d2e19d290931594142c88: [ABCL 10-K executive officers](https://www.sec.gov/Archives/edgar/data/1703057/000170305726000012/abcl-20251231.htm). - alpha:projection-evidence:4f89987e03bcdcef009decbc33bbe0535331a8d140e3c27fd290edb66af94628: [Audit](https://www.sec.gov/Archives/edgar/data/1703057/000162828025020703/abcl-20250429.htm). ## Rights | Field | Value | | --- | --- | | public_retrieval | allowed | | agent_retrieval | allowed | | redistribution | not_granted | | model_training | not_granted | | commercial_use | not_specified | | relationship_pathfinding | not_granted | | direct_contact | not_granted | ## Limitations - Absence of a leadership role, committee, or disclosure is not evidence that it does not exist. - Only explicitly published canonical company identity and current confirmed public roles are included. - Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist. - Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights. - This Company Profile is an identity and evidence record, not an Alpha rating. ## Alternate representations - [Canonical profile](https://registry.alpha.ac/companies/abcellera-biologics-inc) - [Public Markdown](https://registry.alpha.ac/companies/abcellera-biologics-inc.md) - [Public JSON](https://registry.alpha.ac/api/public/companies/abcellera-biologics-inc?format=record) - [JSON-LD](https://registry.alpha.ac/api/public/companies/abcellera-biologics-inc?format=jsonld) - MCP resource: `alpha://companies/abcellera-biologics-inc` at https://mcp.alpha.ac/mcp ## Connected governance records Only explicitly published, rights-cleared records. Missing records do not establish absence, safety, or complete coverage. ## Critical-risk oversight Snapshot as of 2026-10-16T14:49:46.046519+00:00; recorded 2026-10-16T14:49:46.046519+00:00. Every published assignment for this snapshot is listed. Only explicitly reviewed, rights-cleared assignments in effect on the as-of date, in the company's own wording. An assignment shows where oversight is placed, not whether it is effective. Missing records do not establish absence.